AU2002229091A1 - Secreted polypeptide and their use in the treatment of bone disorders - Google Patents

Secreted polypeptide and their use in the treatment of bone disorders

Info

Publication number
AU2002229091A1
AU2002229091A1 AU2002229091A AU2002229091A AU2002229091A1 AU 2002229091 A1 AU2002229091 A1 AU 2002229091A1 AU 2002229091 A AU2002229091 A AU 2002229091A AU 2002229091 A AU2002229091 A AU 2002229091A AU 2002229091 A1 AU2002229091 A1 AU 2002229091A1
Authority
AU
Australia
Prior art keywords
treatment
bone disorders
secreted polypeptide
secreted
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002229091A
Inventor
Audrey Goddard
William I. Wood
Weilan Ye
Zemin Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2001/019692 external-priority patent/WO2002000690A2/en
Priority claimed from PCT/US2001/021735 external-priority patent/WO2002008284A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AU2002229091A1 publication Critical patent/AU2002229091A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002229091A 2001-06-20 2001-12-13 Secreted polypeptide and their use in the treatment of bone disorders Abandoned AU2002229091A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2001278852 2001-06-20
PCT/US2001/019692 WO2002000690A2 (en) 2000-06-23 2001-06-20 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
AU2001271973 2001-07-09
PCT/US2001/021735 WO2002008284A2 (en) 2000-07-20 2001-07-09 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
PCT/US2001/048938 WO2003000729A2 (en) 2001-06-20 2001-12-13 Secreted polypeptide and their use in the treatment of bone disorders

Publications (1)

Publication Number Publication Date
AU2002229091A1 true AU2002229091A1 (en) 2003-01-08

Family

ID=26680506

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002229091A Abandoned AU2002229091A1 (en) 2001-06-20 2001-12-13 Secreted polypeptide and their use in the treatment of bone disorders

Country Status (3)

Country Link
EP (1) EP1397383A2 (en)
AU (1) AU2002229091A1 (en)
WO (1) WO2003000729A2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062891A2 (en) * 2000-02-24 2001-08-30 Human Genome Sciences, Inc. 207 human secreted proteins
WO1998054963A2 (en) * 1997-06-06 1998-12-10 Human Genome Sciences, Inc. 207 human secreted proteins
ATE449108T1 (en) * 1999-03-23 2009-12-15 Genentech Inc SECRETED AND TRANSMEMBRANE POLYPEPTIDES AND NUCLEIC ACID CODING THEREFOR
AU4237700A (en) * 1999-04-15 2000-11-02 Osiris Therapeutics, Inc. Genes and expression products from hematopoietic cells
CA2412211A1 (en) * 2000-06-23 2002-01-03 Genetech, Inc. Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis

Also Published As

Publication number Publication date
WO2003000729A3 (en) 2003-03-06
WO2003000729A2 (en) 2003-01-03
EP1397383A2 (en) 2004-03-17

Similar Documents

Publication Publication Date Title
WO2002086502A8 (en) Methods for the diagnosis and treatment of bone disorders
AU2001286171A1 (en) Human cDNAs and proteins and uses thereof
HUP0401023A3 (en) Use of flibanserin in the treatment of sexual disorders
HK1109160A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2002308348A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
AU2002339128A1 (en) Use of reelin, gas6, and protein s in the treatment of neural disorders
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
WO2003099841A9 (en) Peptides and the use thereof in darkening the skin
GB0128674D0 (en) Treatment of sleep disorders and the like
HUP0400262A3 (en) Glycopeptides, their preparation and use in the treatment of multiple sclerosis
AU2002229091A1 (en) Secreted polypeptide and their use in the treatment of bone disorders
AU6330300A (en) Use of interleukin-6 in treatment of obesity and/or obesity associated disorders
AU2002327176A1 (en) 20 human secreted proteins
AU2002246998A1 (en) 50 human secreted proteins
AU2002365510A1 (en) Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies
AU2002313005B2 (en) Use of glycoprotein for the treatment and re-epithelisation of wounds
AU2002302618A1 (en) 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
AU2001279720A1 (en) Agent for the external treatment of pain and skin disorders
AU2002321141A1 (en) Pyrimidinoxyalkylpiperazines and their therapeutic use
AU2002355470A1 (en) Polymorphisms in the human gene for cyp1a2 and their use in diagnostic and therapeutic applications
AU2002328096A1 (en) Faxigen agonists and antagonists in the treatment of metabolic disorders
AU2002319634A1 (en) Pyrimidine derivatives and their use in the treatment of neurodegenerative diseases
SI1392292T1 (en) Pyranoindazoles and their use for the treatment of glaucoma

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase